|| powered by |
International FANTOM consortium publishes three millstone papers based on large-scale genome-wide data analysis21.04.2009 - (idw) Universitätsklinikum Regensburg
The international FANTOM consortium announces publication of three milestone papers in the prestigious journal Nature Genetics that will challenge current notions of how genes are controlled in mammals.
The FANTOM, or Functional Annotation of the Mammalian cDNA, is a research consortium organized by RIKEN Omics Science Center (OSC) and made up of leading scientists in Australia, Switzerland, Norway, South Africa, Sweden, Canada, Denmark, Italy, Germany, Singapore, UK, and the United States. The consortium has been providing the scientific community with extensive databases on the mammalian genome that describe molecular function, biology, and cell components. FANTOM is now a world authority on the mammalian transcriptome, the set of all messenger RNA, which shows active genetic expression at one point in time. Other major findings include the discovery that approximately 70% of the genome is transcribed, and that more than half of the expressed genes are likely non-coding RNAs (ncRNAs) that do not code proteins; thus, the prevalent idea that only 2% of the genome is transcribed into mRNA coding to proteins needed to be reexamined. Now in its fourth stage, FANTOM4, led by OSC's Yoshihide Hayashizaki, has over 3 years of laborious research developed a novel technology for producing a genome-wide promoter expression profile, established a mathematical scheme for describing the data obtained, and extracted key genomic elements which play dominant roles in maintenance of cellular condition.
In the current research, OSC has broadened its original technology CAGE (Cap Analysis of Gene Expression) and created deepCAGE, which takes advantage of next-generation sequencing to both precisely identify transcription start sites genome-wide as well as to quantify the expression of each start site. The deepCAGE technology was applied to a differentiating acuye myeloid leukemia cell line (ACL) to provide genome-wide time course dynamics of expression at the level of individual promoters -- specific sequences on the DNA providing binding sites for RNA polymerase and the protein transcription factors that recruit them. The consortium built a quantitative model of the genome-wide gene expression dynamics which identified the key regulator motifs driving the differentiation, the time-dependent activities of the transcription regulators binding the motifs, and the genome-wide target promoters of each motif.
Validation of the model was performed by knocking down each transcription factor with small interfering RNAs. This first report of a large-scale gene network based on experimental data set is certain to generate a great deal of excitement in the scientific community. This information is also important for life science and medical researchers who are trying to uncover the processes by which cells undergo conversion or become cancerous, and for those attempting to determine how to control the growth and differentiation of stem cells and ensure their safety for use in regeneration medicine. Dr. Harukazu Suzuki, the scientific coordinator of the consortium, had this to say, "We are proud that we have created groundbreaking research in understanding more about how genes regulate cells at the molecular level and we want to acknowledge all consortium members for their great contribution to the research effort."
The FANTOM consortium has also expanded earlier discoveries of transcriptional complexity by exploring repetitive elements found throughout mammalian genomes with DeepCAGE,. These elements, which constitute up to half of the genome, have been generally considered to be junk or parasitic DNA. However, the team has found that the repetitive elements are broadly expressed and 6 to 30% of mouse and human mRNAs are derived from repetitive element promoters. These RNAs are often tissue-specific and dynamically controlled, and control the output of the genome through a variety of mechanisms. The FANTOM4 collaborators have also identified yet another type of short RNA, referred to as tiRNA (transcription initiation RNA) or tiny RNAs, in the human, chicken, and Drosphilia. They are about 18 nucleotides (nt) in length and are found within -60 to +120 nt of transcription start sites and may actually be widespread in metazoans (animals). A BioMed Central Thematic Series features even more FANTOM 4 research papers in Genome Biology and several BMC journals.
RIKEN Omics Science Center
Director Yoshihide Hayashizaki
Project director Harukazu Suzuki
TEL: +81-45-503-2222 FAX: +81-45-503-9216
Public Relations Office
TEL: +81-48-467-9272 FAX: +81-48-462-4715
http://fantom.gsc.riken.jp/ - FANTOM consortium
http://www.nature.com/ng/journal/vaop/ncurrent/abs/ng.375.html - Nature Genetics
HTML-Code zum Verweis auf diese Seite:
<a href="http://www.uni-protokolle.de/nachrichten/id/175466/">International FANTOM consortium publishes three millstone papers based on large-scale genome-wide data analysis </a>